The Role for Comprehensive NGS Testing in Upper GI Cancers
Medical oncologists discuss the role for comprehensive next-generation sequencing (NGS) in upper GI cancers and the potential role for zolbetuximab.
Treatment Paradigm for Metastatic Upper GI Cancers
Dr Klempner and the Oncology Brothers discuss the treatment paradigm for patients with metastatic upper GI cancers.
Treating Residual Disease in Upper GI Cancers Following FLOT Treatment
The Oncology Brothers and Sam Klempner, MD, offer comprehensive insights on treating residual disease in upper GI cancers following FLOT treatment.
Upper GI Malignancies: Treatment Paradigm for T2 Disease and Beyond
Sam Klempner, MD, joins Rahul Gosain, MD, and Rohit Gosain, MD, to discuss treatment strategies for esophageal, GE junction, and gastric cancers.
Expert Highlights Applications of Proton Therapy in Radiation Oncology
The use of proton therapy may offer a more specific depth charge compared with conventional radiation, according to Timothy Chen, MD.
Novel Radiotherapy Technology Shows “Great Advantage” in Brain Cancer
ZAP-X may provide submillimeter accuracy when administering radiation to patients with brain tumors.
NSCLC: Molecular Testing in the Metastatic Setting
The discussion on biomarker testing practices for patients with non–small cell lung cancer turns its focus to the metastatic setting.
Biomarker Testing in Non–Small Cell Lung Cancer
A panel of medical oncologists introduce themselves and provide clinical insights on biomarker testing practices for patients with non–small cell lung cancer.
Key Takeaways on Evolving Treatment Landscape in Multiple Myeloma
The expert panel provides closing remarks on exciting developments in the evolving treatment landscape in multiple myeloma.
The Role of Molecular Profiling in Optimizing Treatment Decisions for RCC
Molecular profiling is a tool that can best determine first-line therapy options for patients with advanced RCC.
Learning How to Manage Immunotherapy or TKI-Related AEs in Advanced RCC
Clinicians are learning how to identify adverse effects relating to either immunotherapy or tyrosine kinase inhibitors for patients with advanced renal cell carcinoma.
A Multifaceted Approach to Optimizing Treatment in RCC
Moshe Ornstein, MD, discusses the heterogeneous population that comprise patients with advanced renal cell carcinoma.
MM Treatment: Clinical Advice on the Care of Patients Receiving Talquetamab
Tiffany Richards, PhD, ANP-BC, and the rest of the panel offer clinical advice on the care of patients with multiple myeloma who are receiving talquetamab.
The Role of a GPRC5D-Targeting Bispecific in Relapsed/Refractory MM
Beth Faiman, PhD, MSN, describes the role of a GRPC5D-targeting bispecific antibody, talquetamab, in the treatment of patients with relapsed/refractory multiple myeloma.
Treatment Decision-Making in Colon Cancer
Aparna Parikh, MD, and the Oncology Brothers have a comprehensive discussion on treatment decision-making practices for patients with colon cancer, highlighting considerations such as high microsatellite instability and refractory disease.
Treatment Algorithm for Metastatic Colon Cancer
Medical oncologists give an overview of the treatment algorithm for metastatic colon cancer.
The Treatment of Stage III Colon Cancer
The Oncology Brothers and Aparna Parikh, MD, review the treatment algorithm for patients with stage III colon cancer.
The Role of Circulating Tumor DNA in Colon Cancer
Dr Parikh provides insights on the role of circulating tumor DNA in the treatment of patients with colon cancer.
Treating Localized Colon Cancer
Aparna Parikh, MD, joins Rahul Gosain, MD, and Rohit Gosain, MD, to discuss the treatment of patients with localized colon cancer, primarily focusing on stage II disease.
Optimizing Neoadjuvant Therapy Efficacy in dMMR Gastroesophageal Cancer
Tailoring neoadjuvant therapy regimens for patients with mismatch repair deficient gastroesophageal cancer represents a future step in terms of research.
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "A panel of 4 experts on lung cancer")
